Cargando…
Pembrolizumab-Induced Anti-GBM Glomerulonephritis: A Case Report
Immune checkpoint inhibitors are known to have a wide range of autoimmune toxicities, such as acute interstitial nephritis. Immunotherapy induced glomerulonephritis has been described, but anti-glomerular basement membrane disease (anti-GBM) is rarely reported. We present a case report of a 60-year-...
Autores principales: | El Yamani, Nidal, Cote, Gabrielle, Riopel, Julie, Marcoux, Nicolas, Mac-Way, Fabrice, Philibert, David, Agharazii, Mohsen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10320380/ https://www.ncbi.nlm.nih.gov/pubmed/37415622 http://dx.doi.org/10.1016/j.xkme.2023.100682 |
Ejemplares similares
-
Gemella sanguinis endocarditis with c-ANCA/anti-PR-3-associated immune complex necrotizing glomerulonephritis with a ‘full-house’ pattern on immunofluorescence microscopy
por: Rousseau-Gagnon, Mathieu, et al.
Publicado: (2013) -
Crescentic Glomerulonephritis with Anti-GBM and p-ANCA Antibodies
por: Javed, Tariq, et al.
Publicado: (2012) -
Crescentic glomerulonephritis with anti-GBM antibody but no glomerular deposition
por: Sadeghi-Alavijeh, Omid, et al.
Publicado: (2018) -
Rituximab in treatment of anti-GBM antibody glomerulonephritis: A case report and literature review
por: Uematsu-Uchida, Mayu, et al.
Publicado: (2019) -
Regulatory role and mechanisms of myeloid TLR4 in anti-GBM glomerulonephritis
por: Yang, Fuye, et al.
Publicado: (2021)